A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Public ClinicalTrials.gov record NCT01510561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Ph Ib Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
90Y-hPAM4 is administered weekly for 3 weeks combined with 4 weekly doses of gemcitabine to assess. This is a dose escalation study of 90Y-hPAM4 to assess which dose is safe and effective as 3rd line treatment for patients with metastatic pancreatic cancer. Patients are then followed weekly for 12 weeks and afterwards for up to 1 year.
Study identification
- NCT ID
- NCT01510561
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2012 (Actual)
- Primary completion
- Jun 2015 (Estimated)
- Completion
- Sep 2015 (Actual)
- Last update posted
- Aug 19, 2021
2012 – 2015
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Healthcare | Gilbert | Arizona | 85234 | — |
| Scottsdale Healthcare | Scottsdale | Arizona | 85258 | — |
| Christiana Care Health Services Helen Graham Cancer Center | Newark | Delaware | 19713 | — |
| Sylvester Comprehensive Cancer Center Univ. Miami | Miami | Florida | 33136 | — |
| Jackson North Medical Center | Miami | Florida | 33169 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Winship Cancer Institute | Atlanta | Georgia | 30308 | — |
| Mountain States Tumor Institute | Boise | Idaho | 83712 | — |
| Goshen Center for Cancer Care | Goshen | Indiana | 46526 | — |
| Detroit Clinical Research Center | Detroit | Michigan | 48377 | — |
| St. Mary's Trinity Healthcare | Grand Rapids | Michigan | 49503 | — |
| New Mexico Cancer Care Alliance | Albuquerque | New Mexico | 87131 | — |
| Weill Cornell NY Presbyterian Hospital | New York | New York | 10021 | — |
| Mt. Sinai Medical Center | New York | New York | 10029 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | 27599 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Kimmel Cancer Center at Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Institute of Translational Oncology Research | Greenville | South Carolina | 29605 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| VA Oncology Associates | Norfolk | Virginia | 23502 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01510561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01510561 live on ClinicalTrials.gov.